Copyright © 2001 by the European Society of Cardiology.
Editorials
Recurrence of atrial fibrillation and the need for new definitions
a Department of Cardiology, University of Maastrict, The Netherlands
b Department of Cardiology, University of Groningen, The Netherlands
References
- Fuster V, Rydén LE, Asinger RW. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Scientific and Clinical Initiatives Committee. Eur Heart J. 2001;22:
- Timmermans C, Rodriguez LM, Smeets JL, Wellens HJ. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol. 1998;9:122–128[Web of Science][Medline]
- Tieleman RG, Van Gelder IC, Crijns HJ. Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol. 1998;31:167–173
[Abstract/Free Full Text] - Fynn SP, Todd DM, Hobbs WJC, Armstrong KL, Garratt CJ. Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation: a manifestation of atrial electrical remodelling in humans? Eur Heart J. 2001;22:1822–1834
[Abstract/Free Full Text] - Wijffels MCEF, Dorland R, Mast F, Allessie MA. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation. Circulation. 2000;102:260–267
[Abstract/Free Full Text] - Van Gelder IC, Crijns HJ, Tieleman RG. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med. 1996;156:2585–2592
[Abstract/Free Full Text] - Van der Velden HM, Ausma J, Rook MB. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res. 2000;46:476–486
[Abstract/Free Full Text] - Li D, Melnyk P, Feng J. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation. 2000;101:2631–2638
[Abstract/Free Full Text]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Sticherling, S. Behrens, W. Kamke, A. Stahn, and M. Zabel Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion Europace, January 1, 2005; 7(6): 546 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.L. Botto, M. Luzi, and A. Sagone Atrial fibrillation: the remodelling phenomenon Eur. Heart J. Suppl., September 1, 2003; 5(suppl_H): H1 - H7. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Stabile, P. Turco, A. De Simone, A. H. Madrid, M. G Bueno, J. M.G. Rebollo, I. Marin, G. Pena, E. Bernal, A. Rodriguez, et al. Pretreatment of Patients With Atrial Fibrillation Who Undergo Electrical Cardioversion * Response Circulation, March 25, 2003; 107 (11): e75 - e75. [Full Text] [PDF]
|
|
|
|
 |
|
 H.-F. Tse and C.-P. Lau Electrophysiologic actions of dl-sotalolin patients with persistent atrial fibrillation J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2150 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sticherling, M. Ozaydin, H. Tada, H. Oral, F. Pelosi, B. P. Knight, S. A. Strickberger, and F. Morady Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2002; 7(3): 155 - 160. [Abstract] [PDF]
|
|
|
|
|
|
A. H. Madrid, M. G. Bueno, J. M.G. Rebollo, I. Marin, G. Pena, E. Bernal, A. Rodriguez, L. Cano, J. M. Cano, P. Cabeza, et al. Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study Circulation, July 16, 2002; 106(3): 331 - 336. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||